Contraceptive implants in Kenya: current status and future prospects

Contraception

Volumn 75, Issue 6, 2007, Pages 468-473

  Hubacher, David ^a   Kimani, Joshua ^a   Steiner, Markus J ^a   Solomon, Marsden ^a   Ndugga, Maggwa Baker ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

Benefits; Contraceptive implant; Kenya; Long acting contraception; Unintended pregnancy

Indexed keywords

CONTRACEPTIVE AGENT; LEVONORGESTREL;

ARTICLE; CONTRACEPTION; CONTROLLED STUDY; DRUG IMPLANTATION; DRUG USE; FAMILY PLANNING; HUMAN; KENYA; QUESTIONNAIRE; UNPLANNED PREGNANCY;

CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; COST-BENEFIT ANALYSIS; DELAYED-ACTION PREPARATIONS; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; KENYA; LEVONORGESTREL; PREGNANCY; PREGNANCY, UNPLANNED; WOMEN'S HEALTH SERVICES;

EID: 34249326980     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.02.008     Document Type: Article

References (25)

1. RHInterchange. Global summary of shipments report. http://rhi.rhsupplies.org/rhi/shipmentsummary.do?locale=en_US [Accessed August 9, 2006]
2. Shelton J. New USAID award for contraceptive implants (Jadelle). Center for Communication Programs, Johns Hopkins Bloomberg School of Public Health. http://www.jhuccp.org/pearls/pearl.php?id=342 [Accessed November 28, 2006]
3. MEASURE DHS. Demographic and Health Surveys. http://www.measuredhs.com/aboutsurveys/dhs/start.cfm [Accessed November 28, 2006]
4. MEASURE DHS. Service Provision Assessment Surveys. http://www.measuredhs.com/aboutsurveys/spa.cfm [Accessed November 28, 2006]
5. Mavranezouli I., and Wilkinson C. Long-acting reversible contraceptives: not only effective, but also a cost-effective option for the National Health Service. J Fam Plann Reprod Health Care 32 (2006) 3-5
6. National Collaborating Centre for Women's and Children's Health. Long-acting reversible contraception: full guideline. Royal College of Obstetricians and Gynaecologists. http://www.nice.org.uk/guidance/CG30/guidance/pdf/English [Accessed February 23, 2007]
7. Sivin I., Nash H., and Waldman S. Jadelle levonorgestrel rod implants: a summary of scientific data and lessons learned from programmatic experience (2002), The Population Council, New York
8. Bradley J.E., Dwyer J., and Levin K.J. Norplant expansion in Kenya. Afr J Reprod Health 5 (2001) 89-98
9. Ruminjo J.K., Achwal I., and Ruminjo I.N. Acceptability of Norplant contraceptive subdermal implants in Kenya. East Afr Med J 71 (1994) 558-561
10. Demographic and Health Surveys. Kenya 1993 final report. http://www.measuredhs.com/pubs/pub_details.cfm?ID=95&PgName=country &ctry_id=20 [Accessed August 5, 2006]
11. Demographic and Health Surveys. Kenya 1989 final report. http://www.measuredhs.com/pubs/pub_details.cfm?ID=312&PgName=country &ctry_id=20 [Accessed August 5, 2006]
12. Demographic and Health Surveys. Kenya 1998 final report. http://www.measuredhs.com/pubs/pub_details.cfm?ID=66&PgName=country &ctry_id=20 [Accessed August 5, 2006]
13. Demographic and Health Surveys. Kenya 2003 final report. http://www.measuredhs.com/pubs/pub_details.cfm?ID=462&PgName=country &ctry_id=20 [Accessed August 5, 2006]
14. National Coordinating Agency for Population and Development (NCAPD) [Kenya], Ministry of Health, Central Bureau of Statistics, ORC Macro. Kenya Service Provision Assessment Survey (SPA) 2004. http://www.measuredhs.com/pubs/pub_details.cfm?ID=561&PgName=country &ctry_id=20 [Accessed August 5, 2006]
15. Population Reference Bureau. Family planning worldwide. 2002 Data sheet. http://www.prb.org/pdf/FamPlanWorldwide_eng.pdf [Accessed August 11, 2006]
16. UNICEF. Kenya health statistics. http://www.unicef.org/infobycountry/kenya_statistics.html [Accessed November 28, 2006]
17. Cleland J., Bernstein S., Ezeh A., Faundes A., Glasier A., and Innis J. Family planning: the unfinished agenda. Lancet 368 (2006) 1810-1827
18. Glasier A., and Shields W.C. Can we improve contraceptive use?. Contraception 73 (2006) 1-3
19. Chiou C.F., Trussell J., Reyes E., et al. Economic analysis of contraceptives for women. Contraception 68 (2003) 3-10
20. National Collaborating Centre for Women's and Children's Health. Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception. Royal College of Obstetricians and Gynaecologists. http://www.nice.org.uk/page.aspx?o=275466 [Accessed February 15, 2007]
21. Varney S.J., and Guest J.F. Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK. Pharmacoeconomics 22 (2004) 1141-1151
22. Trussell J., Leveque J.A., Koenig J.D., et al. The economic value of contraception: a comparison of 15 methods. Am J Public Health 85 (1995) 494-503
23. Fraser I.S., Tiitinen A., Affandi B., et al. Norplant consensus statement and background review. Contraception 57 (1998) 1-9
24. Hardee K., Balogh S., and Villinski M.T. Three countries' experience with Norplant introduction. Health Policy Plan 12 (1997) 199-213
25. Tolley E., and Nare C. Access to Norplant removal: an issue of informed choice. Rev Afr Sante Reprod 5 (2001) 90-99